Vaxcyte Inc

29 paź 2026, 20:07 UTC

Vaxcyte, Inc. shares closed higher on Thursday, despite pulling back from an earlier session high, ending 2.83% below the 20-day moving average.

28 paź 2026, 22:36 UTC

Vaxcyte, Inc. is trading modestly lower in after-market hours, having retraced from an initial drop shortly after the market closed.

27 paź 2026, 19:23 UTC

Mizuho assigns an Outperform rating to Vaxcyte with a price target of $163.00, citing potential benefits from Pfizer's PCV25 study insights.

26 paź 2026, 19:16 UTC

Vaxcyte Inc shares fell sharply, continuing a downward trend over the last four sessions and remaining well below the 20-day moving average.

23 paź 2026, 22:16 UTC

Vaxcyte Inc shares advanced in after-market trading, recovering from a recent decline, amid robust economic indicators supporting the biotechnology sector.

22 paź 2026, 20:07 UTC

Shares of Vaxcyte Inc. fell modestly as negative market reaction to Moderna's cancer vaccine trial results impacted several biotech holdings.

21 paź 2026, 19:51 UTC

Vaxcyte Inc shares are declining as Mizuho noted immune responses for its PCV 25 vaccine candidate appear lower than those of PCV20 for most serotypes.

20 paź 2026, 20:01 UTC

Vaxcyte Inc shares are advancing, supported by the SPDR S&P Biotech ETF's rise amid strong performances from key holdings, including Moderna and Revolution Medicines.

19 paź 2026, 20:01 UTC

State Street SPDR S&P Biotech ETF is higher, moving in sympathy with Vaxcyte Inc, which remains above its 20-day moving average after earlier gains.

16 paź 2026, 20:21 UTC

Vaxcyte Inc shares are declining in after-market hours, influenced by economic data indicating inflationary pressures and potential interest rate hikes from the Federal Reserve.

15 paź 2026, 23:06 UTC

Vaxcyte Inc's shares are roughly flat in after-market hours, remaining around the middle of their one-month range and above the 20-day moving average.

14 paź 2026, 23:06 UTC

Vaxcyte Inc shares declined modestly in after-market trading amid broader market weakness as major indices fell due to rising core inflation concerns.

13 paź 2026, 23:06 UTC

Vaxcyte Inc shares advanced modestly in after-market trading, following three consecutive lower daily closes, while the Direxion Daily S&P Biotech Bull 3X ETF also increased.

12 paź 2026, 20:51 UTC

Vaxcyte Inc shares are trading lower in after-market hours, reversing a trend of higher daily closes observed since Monday's close.

9 paź 2026, 20:01 UTC

Vaxcyte Inc shares are advancing, continuing a trend of sharp gains since Thursday's close, with unusually high trading volume reported today.

8 paź 2026, 19:50 UTC

Vaxcyte Inc shares fell sharply, diverging from recent gains, despite completing approximately $1 billion in funding following positive Phase 3 data for its VAX-31 vaccine.

7 paź 2026, 22:11 UTC

Vaxcyte Inc is declining in after-market trading, continuing a trend of three consecutive lower daily closes, though it remains above its 20-day moving average.

6 paź 2026, 20:02 UTC

Vaxcyte Inc shares fell sharply as the company announced public offerings totaling $1 billion, raising concerns over potential equity dilution amid pricing uncertainty.

5 paź 2026, 23:01 UTC

Vaxcyte Inc announced $1 billion in dual public offerings for common stock and convertible notes, leading to a significant decline in after-market trading.

2 paź 2026, 20:12 UTC

Vaxcyte Inc's shares advanced in after-market trading following Friday's close, holding steady near the lower end of its one-month range.

1 paź 2026, 20:13 UTC

Vaxcyte Inc's shares advanced in after-market hours, gaining ground since the prior close, despite remaining significantly below its 20-day moving average.

29 wrz 2026, 19:55 UTC

Vaxcyte Inc shares fell sharply, trading significantly below their 20-day moving average and near the lower end of their one-month range.

28 wrz 2026, 20:07 UTC

Vaxcyte Inc shares are trading higher as B of A Securities maintains its Buy rating while lowering the price target to $130.

24 wrz 2026, 19:46 UTC

Vaxcyte Inc is trading modestly higher, having fluctuated throughout the day but remains below its 20-day moving average and near the lower end of its one-month range.

23 wrz 2026, 20:02 UTC

Vaxcyte Inc shares fell sharply, influenced by a significant drop in the Direxion Daily S&P Biotech Bull 3X ETF and earlier session highs.

18 wrz 2026, 20:02 UTC

Vaxcyte Inc shares fell sharply, reaching their lowest cumulative return since Thursday and remaining well below the 20-day moving average.

17 wrz 2026, 20:07 UTC

Vaxcyte Inc is gaining, likely influenced by the SPDR S&P Biotech ETF's rise following positive Phase 3 results from Moderna's cancer vaccine.

16 wrz 2026, 19:16 UTC

Vaxcyte Inc shares fell amid broader market volatility following the Federal Reserve's 25 basis point interest rate hike, remaining near the lower end of their one-month range.

14 wrz 2026, 20:08 UTC

Vaxcyte Inc shares are higher today, reflecting broader market trends. Earlier in the session, the stock pulled back but remains above Friday's close.

9 wrz 2026, 19:46 UTC

Vaxcyte Inc shares are lower today, fluctuating from an early gain to a mid-afternoon decline. The stock is near its one-month trading range low.